Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Year-over-year total asset growth rate
Percentile
P31
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -7.55% |
| Q3 2025 | 34.18% |
| Q2 2025 | 1.88% |
| Q1 2025 | -4.38% |
| Q4 2024 | -2.89% |
| Q3 2024 | -2.41% |
| Q2 2024 | 1.62% |
| Q1 2024 | 68.96% |
| Q4 2023 | 169.18% |
| Q3 2023 | -21.32% |
| Q2 2023 | -9.02% |
| Q1 2023 | -8.31% |
| Q4 2022 | 128.54% |
| Q3 2022 | -26.69% |
| Q2 2022 | -2.82% |
| Q1 2022 | -18.54% |
| Q4 2021 | -10.29% |
| Q3 2021 | -7.09% |
| Q2 2021 | 5.88% |
| Q1 2021 | 7.92% |
| Q4 2020 | -15.49% |
| Q3 2020 | -12.56% |
| Q2 2020 | -5.61% |
| Q1 2020 | -6.92% |
| Q4 2019 | -3.11% |
| Q3 2019 | -2.89% |
| Q2 2019 | -2.03% |
| Q1 2019 | -1.21% |
| Q4 2018 | -0.84% |
| Q3 2018 | -0.40% |
| Q2 2018 | 167.89% |
| Q1 2018 | -4.59% |
| Q4 2017 | 206.08% |
| Q3 2017 | -7.69% |
| Q2 2017 | 68.66% |
| Q1 2017 | -2.07% |
| Q4 2016 | -0.72% |
| Q3 2016 | -7.63% |
| Q2 2016 | -15.16% |
| Q1 2016 | -22.33% |